WallStSmart
ABBV

AbbVie Inc

NYSE: ABBV · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$211.32
+3.64% today

Updated 2026-04-30

Market cap
$360.63B
P/E ratio
99.95
P/S ratio
5.90x
EPS (TTM)
$2.04
Dividend yield
52W range
$171 – $239
Volume
7.0M

AbbVie Inc (ABBV) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$5.37B$4.98B$6.25B$6.34B$6.27B$3.55B$7.54B$7.04B$9.96B$13.43B$13.32B$17.59B$22.78B$24.94B$22.84B$18.81B$19.03B
Capital expenditures$312.56M$448.00M$355.51M$333.00M$491.00M$612.00M$532.00M$479.00M$529.00M$638.00M$552.00M$798.00M$787.00M$695.00M$777.00M$974.00M$1.21B
Depreciation
Stock-based comp$156.72M$167.00M$162.98M$187.00M$212.00M$241.00M$282.00M$353.00M$365.00M$421.00M$430.00M$753.00M$692.00M$671.00M$747.00M$911.00M$955.00M
Free cash flow$5.05B$4.53B$5.89B$6.01B$5.78B$2.94B$7.00B$6.56B$9.43B$12.79B$12.77B$16.79B$21.99B$24.25B$22.06B$17.83B$17.82B
Investing cash flow
Financing cash flow
Dividends paid$2.56B$2.66B$3.29B$3.72B$4.11B$5.58B$6.37B$7.72B$9.26B$10.04B$10.54B$11.03B$11.66B
Share repurchases
Debt repayment
Net change in cash$3.69B$-1.25B$51.00M$-3.30B$4.20B$-2.01B$32.63B$-31.48B$1.30B$-483.00M